Safety profile of Sibutramine during a 6-week treatment period in high-risk patients with cardiovascular disease and/or diabetes - an analysis of the Sibutramine Cardiovascular Outcomes (SCOUT) Trial

被引：0
|
作者：
Maggioni, Aldo
Caterson, Ian
Coutinho, Walmir
Finer, Nick
Van Gaal, Luc
Sharma, Arya
Pedersen, Christian
James, W. Philip
机构：
[1] ANMCO Res Ctr, Florence, Italy
[2] Univ Sydney, Sydney, NSW 2006, Australia
[3] Catholic Univ, Rio De Janeiro, Brazil
[4] Univ Cambridge, Wellcome Trust Clin Res Facility, Cambridge CB2 1TN, England
[5] Univ Hosp, Antwerp, Belgium
[6] McMaster Univ, Hamilton, ON L8S 4L8, Canada
[7] Bispebjerg Hosp, Copenhagen, Denmark
[8] London Sch Hyg & Trop Med, London WC1, England
来源：
INTERNATIONAL JOURNAL OF OBESITY | 2007年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S167 / S167
页数：1
相关论文
共 50 条
  • [41] Risk of cardiovascular outcomes with bempedoic acid in high-risk statin intolerant patients: a systematic review and meta analysis
    Hamayal, Muhammad
    Shahid, Warda
    Akhtar, Chaudhary Humayun
    Shekiba, Fnu
    Iftikhar, Iqra
    Tahir, Muhammad Danyal
    Awwab, Muhammad
    Hussain, Saima
    Naeem, Saman
    Hafeez, Momina
    FUTURE CARDIOLOGY, 2024, 20 (11-12) : 639 - 650
  • [42] Cardiovascular Outcomes According to Urinary Albumin and Kidney Disease in Patients With Type 2 Diabetes at High Cardiovascular Risk Observations From the SAVOR-TIMI 53 Trial
    Scirica, Benjamin M.
    Mosenzon, Ofri
    Bhatt, Deepak L.
    Udell, Jacob A.
    Steg, Ph Gabriel
    McGuire, Darren K.
    Im, KyungAh
    Kanevsky, Estella
    Stahre, Christina
    Sjostrand, Mikaela
    Raz, Itamar
    Braunwald, Eugene
    JAMA CARDIOLOGY, 2018, 3 (02) : 155 - 163
  • [43] The Safety Profile Of Inclisiran In Patients With Dyslipidemia And Intermediate To High Atherosclerotic Cardiovascular Disease Risk: A Systematic Review And Meta-Analysis
    Maliha, Maisha
    Satish, Vikyath
    Chi, Kuan Yu
    Kumar, Sriram Sunil
    Kharawala, Amrin
    Duarte, Gustavo
    Mangeshkar, Shaunak
    Borkowski, Pawel
    Osabutey, Anita
    GAshi, Eleonora
    Behuria, Supreeti
    CIRCULATION, 2024, 150
  • [44] Cardiovascular and renal outcomes with varying degrees of kidney disease in high-risk people with type 2 diabetes: An epidemiological analysis of data from the AMPLITUDE-O trial
    Gerstein, Hertzel C.
    Mian, Rajibul
    Ramasundarahettige, Chinthanie
    Branch, Kelley R. H.
    Del Prato, Stefano
    Lam, Carolyn S. P.
    Lopes, Renato D.
    Pratley, Richard
    Rosenstock, Julio
    Sattar, Naveed
    DIABETES OBESITY & METABOLISM, 2024, 26 (04): : 1216 - 1223
  • [45] Comprehensive evaluation of cardiovascular efficacy and safety outcomes of SGLT2 inhibitors in high risk patients of cardiovascular disease: systematic review and meta-analysis
    Bhattarai, Mukul
    Salih, Mohsin
    Regmi, Manjari
    Al-akchar, Mohammad
    Koester, Cameron
    Ibrahim, Abdisamad
    Parajuli, Priyanka
    Garcia, Odalys Lara
    Bhandari, Bishal
    Rehman, Anis
    Siddique, Momin
    CARDIOVASCULAR ENDOCRINOLOGY & METABOLISM, 2021, 10 (02): : 89 - 98
  • [46] Consumption of Plant Foods and Its Association with Cardiovascular Disease Risk Profile in South Africans at High-Risk of Type 2 Diabetes Mellitus
    Lopes, Tatum
    Zemlin, Annalise E.
    Hill, Jillian
    Mchiza, Zandile J.
    Peer, Nasheeta
    Erasmus, Rajiv T.
    Kengne, Andre P.
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (20)
  • [47] Effect of Time to Titration to Maximum Dose of Statins on Cardiovascular Outcomes A Retrospective Analysis in High-Risk Patients
    Friend, Amy S.
    Kamalesh, Masoor
    Schellhase, Ellen
    Eckert, George J.
    Evans, Tamara S.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2009, 9 (02) : 103 - 107
  • [48] Interleukin-6 and Cardiovascular Outcomes in Patients with Type 2 Diabetes: A Post Hoc Analysis of CANVAS Trial
    Koshino, Akihiko
    Schechter, Meir
    Sen, Taha
    Neuen, Brendon
    Arnott, Clare
    Perkovic, Vlado
    Hansen, Michael K.
    Heerspink, Hiddo L.
    DIABETES, 2022, 71
  • [49] High-dose influenza vaccine to reduce clinical outcomes in high-risk cardiovascular patients: Rationale and design of the INVESTED trial
    Vardeny, Orly
    Udell, Jacob A.
    Joseph, Jacob
    Farkouh, Michael E.
    Hernandez, Adrian F.
    McGeer, Alison J.
    Talbot, H. Keipp
    Bhatt, Deepak L.
    Cannon, Christopher P.
    Goodman, Shaun G.
    Anand, Inder
    DeMets, David L.
    Temte, Jon
    Wittes, Janet
    Nichol, Kristin
    Yancy, Clyde W.
    Gaziano, J. Michael
    Cooper, Lawton S.
    Kim, KyungMann
    Solomon, Scott D.
    AMERICAN HEART JOURNAL, 2018, 202 : 97 - 103
  • [50] Aspirin as a Primary Prevention of Cardiovascular Disease in High-Risk New Diabetes Patients: A Retrospective Cohort Study in Taiwan
    Chiang, Chiawei
    Chen, Ta-Cheng
    Yeh, Yi-Chun
    Chen, Yen-Yu
    NEUROLOGY, 2019, 92 (15)
12345